eli lilly sues compounders for selling unapproved copies of tirzepatide Weight loss drug lawsuit: Mounjaro maker files suit over compounded products Eli Lilly sues Houston compound

While GI side effects are common with semaglutide, severe abdominal pain could indicate pancreatitis, a rare but serious side effect that requires medical evaluation

Speak with your GP or Nurse Practitioner to determine which treatment suits you best

As a physician in Obesity Medicine, having managed patients on GLP-1 therapies for over a decade across both the US and India, a few thoughts to gently add

In people with obesity or type 2 diabetes, this system gets broken

Jain AB, Ali A, Gorgojo Martnez JJ, Hramiak I, Kavia K, Madsbad S, Potier L, Prohaska BD, Strong JL, Vilsbll T (2021) Switching between GLP-1 receptor agonists in clinical practice: expert consensus and practical guidance

The appetite-control benefit of GLP-1 medications is difficult to replicate through behavior alone, especially for individuals with genetic predispositions to high appetite drive